XRCC6 and cancer: UMI-77, as an effective Ku70/80 protein complex (Ku) inhibitor, disrupts bleomycin-induced DNA damage repair, sensitizes various cancer cells to DNA-damaging drugs, and considerably enhances the effects of other antitumor drugs (Chen et al., 2024).